What Causes Drowsiness in Cancer Patients?

Drowsiness is common in cancer patients and can impair quality of life. Although often considered alongside fatigue, it is characterized more specifically by reduced alertness, slower reactions and daytime sleepiness. By affecting cognitive and physical function, it may also reduce treatment adherence.

Pathophysiology

Several mechanisms contribute to drowsiness in cancer patients:

• Central Nervous System Effects: Metastases, inflammation and cytokine release may suppress wakefulness centers.
• Hormonal Disturbances: Cortisol, melatonin and thyroid hormones may become dysregulated.
• Anemia: Reduced oxygen-carrying capacity can slow brain function.
• Immune Response: Proinflammatory cytokines such as IL-1, IL-6 and TNF-alpha can affect hypothalamic sleep centers, producing sedation.

Underlying Causes

Related to the Primary Disease:

• Metabolic effects of advanced cancer
• Brain metastases or leptomeningeal involvement

Treatment-Related:

• Chemotherapy drugs: particularly thalidomide, lenalidomide and taxanes
• Supportive treatments: opioids, benzodiazepines (e.g. lorazepam), antihistamines
• Corticosteroids: can disrupt circadian rhythms, causing both insomnia and daytime sleepiness.

Comorbid Conditions:

• Depression, anxiety
• Sleep apnea, insomnia
• Electrolyte disorders, hypoglycemia, hypothyroidism

Clinical Features

Patients commonly report:

• Sudden daytime sleepiness
• Reduced attention and concentration
• Fatigue unrelieved by rest
• Reduced physical activity.

Drowsiness may last weeks or months in some patients and can persist even after treatment ends.

Diagnosis and Assessment

• Clinical history and physical examination
• Complete blood count, electrolytes, thyroid function tests
• Medication review
• Psychosocial assessment: depression and anxiety scales
• Polygraphy or sleep disorder testing when needed

Treatment and Management Approaches

Drowsiness is a complex symptom usually arising from interacting factors rather than one cause. Management should therefore be individualized, multidisciplinary and stepwise. The following sections outline this process.

1-Identifying and Treating the Underlying Cause

Anemia-Related Drowsiness

Diagnosis: Hemoglobin < 11 g/dL

Treatment:

• For iron deficiency: oral/parenteral iron
• For chemotherapy-induced anemia: erythropoietin (epoetin alfa, darbepoetin alfa)
• For patients requiring transfusion: packed red blood cells

Electrolyte Imbalances

Hyponatremia, hypercalcemia and hypokalemia can cause drowsiness.

Example:

• A patient with metastatic breast cancer may develop sedation from hypercalcemia; intravenous fluids and bisphosphonate treatment (zoledronic acid) are given.

Endocrine Disorders

Hypothyroidism, adrenal insufficiency, diabetes mellitus

Treatment Examples:

• If thyroid-stimulating hormone (TSH) is elevated, levothyroxine may be started.
• For corticosteroid withdrawal: low-dose hydrocortisone replacement

2-Managing Medication-Induced Drowsiness

 Medication Review and Dose Adjustment

Opioids: Morphine, fentanyl and oxycodone can initially cause sedation.

Management: reduce the dose, change the drug (for example, from morphine to fentanyl) or adjust administration timing

Benzodiazepines: Lorazepam and diazepam may cause drowsiness.

Management: limit duration of use or switch to alternatives such as SSRIs/SNRIs

Antihistamines: H1 antagonists such as diphenhydramine can cause marked sedation, particularly in older patients.

Management: discontinue or replace with second-generation nonsedating antihistamines, such as loratadine

Adjusting Timing

Giving medications that impair daytime alertness at night can make use of their sedating effect.

Example: nighttime gabapentin may relieve both neuropathic pain and insomnia.

3. Nonpharmacological Interventions

Regular Physical Activity

Light-to-moderate exercise, such as 20-30 minutes of walking daily, may reduce drowsiness by increasing muscle activity and brain circulation.

Particularly effective for reducing post-chemotherapy fatigue.

Example Program:

• 15 minutes of light exercise in the morning + a 5–10-minute afternoon walk

Improving Sleep Hygiene

• Sleep in an environment free from stimulating distractions
• Go to bed and wake up at the same time daily
• Avoid caffeine, alcohol and screen exposure
• Melatonin supplementation may be recommended if needed.

Psychosocial Interventions

• Mood-related problems such as depression, anxiety and distress are associated with drowsiness.
• Cognitive behavioral therapy (CBT) is effective for managing fatigue and sleep problems in cancer patients.
• Mindfulness, meditation and breathing exercises may reduce stress and improve overall energy.

4. Behavioral and Daily Living Strategies

• Energy management: schedule mentally demanding tasks when energy is highest, usually in the morning.
• Symptom diary: daily records of drowsiness, medication use and activity levels help identify causes.
• Family/social support: assistance with daily activities improves functioning.

5. Medical Interventions (Selected Cases)

• Psychostimulants may be considered for some patients with drowsiness and severe cancer-related fatigue:
• Modafinil: studied particularly in patients with brain tumors and multiple sclerosis.
• Methylphenidate: may be used in selected oncology settings to improve energy.
• These agents require careful patient selection and close monitoring.

Conclusion

Drowsiness substantially affects cancer patients' quality of life, yet is often overlooked. Effective management requires systematic assessment of underlying causes and an individualized, multidisciplinary approach. Care should combine medical, psychological, social and behavioral components within a holistic framework.